GoHealth, Inc. — fact timeline

GoHealth, Inc. reported financial results for the twelve months ended December 31, 2025.

“On March 31, 2026 , GoHealth, Inc. issued a press release announcing its financial results for the twelve months ended December 31, 2025.”

GoHealth, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5550(b)(1), 5550(b)(3)).

“March 18, 2026, GoHealth, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires listed companies on The Nasdaq Global Market to maintain a minimum market value of listed securities of $35 million (the “MVLS Requirement”). The Notice also indicates that the Company does not meet the alternative continued listing standards set forth in Nasdaq Listing Rules 5550(b)(1) and 5550(b)(3), which require listed”

GoHealth, Inc. incurred term loan of $115,000,000 with Blue Torch Finance, LLC at Term SOFR plus 5.50% or Alternate Base Rate plus 4.50% maturing August 5, 2029.

“the Borrower entered into a Superpriority Senior Secured Credit Agreement (the “Priming Credit Agreement”), with Holdings, the lenders party thereto, and Blue Torch Finance, LLC, as administrative agent and as collateral agent. The Priming Credit Agreement governs a senior secured super priority term loan facility in an aggregate principal amount of $115.0 million (the “Priming Facility”)”

Katherine O'Halloran changed role as Chief Accounting Officer at GoHealth, Inc..

“Ms. O’Halloran, the Company’s current Interim Chief Financial Officer, will continue her service to the Company as Chief Accounting Officer following Mr. Shanahan’s appointment as Chief Financial Officer.”

Brendan Shanahan was appointed as Chief Financial Officer at GoHealth, Inc..

“appointed Brendan Shanahan as the Company’s Chief Financial Officer, effective October 14, 2024”

Christopher C. Litchford resigned as Director at GoHealth, Inc..

“On July 8, 2024, Christopher C. Litchford, a member of the Board, informed the Company of his intent to resign from the Board effective July 8, 2024.”

Abhiraj R. Modi was appointed as Director at GoHealth, Inc..

“On July 9, 2024, the Board appointed Abhiraj R. Modi as a Class II director of the Board.”

Alan Wheatley was appointed as Director at GoHealth, Inc..

“On July 9, 2024, the Board of Directors (the “Board”) of GoHealth, Inc. (the “Company”) appointed Alan Wheatley as a Class II director of the Board, effective immediately.”

Alexander Timm was appointed as Lead Independent Director at GoHealth, Inc..

“Alexander Timm will replace Mr. Flanagan as lead independent director.”

Joseph G. Flanagan resigned as Director at GoHealth, Inc..

“Joseph G. Flanagan, a member of the Board of Directors (the “Board”) of GoHealth, Inc. (the “Company”), informed the Company of his intent to resign from the Board effective June 25, 2024.”

Katherine O'Halloran was appointed as Interim Chief Financial Officer at GoHealth, Inc..

“The Company further announced the appointment of Chief Accounting Officer, Katherine O’Halloran, age 53, as the Interim Chief Financial Officer on June 4, 2024 while the Company searches for a permanent replacement.”

Jason Schulz resigned as Chief Financial Officer at GoHealth, Inc..

“On June 4, 2024, GoHealth, Inc. (the “Company”) announced the resignation of Jason Schulz as Chief Financial Officer.”

GoHealth, Inc. reported the quarter ended March 31, 2024 results: revenue $185.6 million, net income net loss of $21.3 million.

“digital health company, today announced financial results for the three months ended March 31, 2024. First Quarter Highlights • First quarter 2024 net revenues of $185.6 million, a slight increase compared to $183.2 million in the prior year period. • First quarter 2024 Submissions of 216,148, a 2,503 increase compared to 213,645 Submissions in the prior”